US Cancer Survivors Reach 18.6 Million and Projected to Surpass 22 Million by 2035
The U.S. cancer survivor population is projected to grow from 18.6 million in 2025 to over 22 million by 2035, highlighting the need for equitable care and survivorship support.
As of January 1, 2025, approximately 18.6 million individuals in the United States are living with a history of cancer, according to the latest report titled "Cancer Treatment and Survivorship Statistics, 2025" by the American Cancer Society (ACS). This figure is expected to grow substantially, with projections indicating that the number of cancer survivors will exceed 22 million by the year 2035. The study highlights disparities in treatment access and outcomes among various cancer types and demographic groups.
The most common cancers among men include prostate (over 3.5 million cases), melanoma (over 800,000 cases), and colorectal cancer (around 730,000 cases). Among women, breast cancer (approximately 4.3 million cases), uterine corpus, and thyroid cancers are prevalent. Notably, over half of the survivors diagnosed within the past decade, and nearly 80% are aged 60 and older.
Survivor distribution varies by state, with California reporting nearly two million survivors and smaller states like Wyoming and the District of Columbia having significantly fewer, largely due to population differences. The number of female breast cancer survivors is projected to reach about 5.3 million by 2035, showing the largest growth among common cancers.
The report also reveals racial disparities in treatment. Black patients are less likely to receive surgery for early-stage lung and rectal cancers compared to white patients, highlighting ongoing equity issues. Uninsured individuals diagnosed with early-stage colorectal cancer tend to have lower five-year survival rates than those with private insurance.
Experts emphasize the importance of equitable access to high-quality care and early detection programs. Dr. Nikita Sandeep Wagle from the ACS underscores that many survivors face long-term effects from treatment, financial challenges, and fear of recurrence. Addressing these issues is crucial for improving survivorship quality.
The findings are based on comprehensive data from several national sources, including cancer registries, insurance records, and population surveys. As advances in treatment continue, the number of survivors is expected to rise, necessitating ongoing efforts to reduce disparities and support survivorship needs.
Source: https://medicalxpress.com/news/2025-05-cancer-survivors-million-exceed.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Unexpected Damaging Effects Found in Parkinson's Disease Drug Candidates
Recent research uncovers that promising Parkinson's drug candidates may cause mitochondrial damage instead of promoting cellular health, highlighting the need for better drug testing methods. Source: https://medicalxpress.com/news/2025-08-parkinson-disease-drug-candidates-unexpected.html
Digital Inhalers Show Promise in Early Detection of COPD Flare-Ups
Innovative digital inhalers with remote monitoring capabilities may help predict COPD flare-ups early, enabling better disease management and improved patient outcomes.
Using AI to Restore Speech in Paralyzed Stroke Survivor After 18 Years
Scientists have used AI-driven brain-computer interface technology to help a stroke survivor regain her ability to speak after 18 years of paralysis, marking a major step in neuroprosthetic advancements.
Real-Time AI Trial Demonstrates Potential to Accelerate Cancer Diagnosis and Treatment
A recent study demonstrates how AI can analyze routine pathology slides to predict genetic mutations in lung cancer, potentially reducing the need for extensive genetic testing and speeding up personalized treatment decisions.